Acne is described as a chronic skin disorder in which the hair follicles will become blocked and/or inflamed. There exist several variants of acne that ranges from mild to severe acne. The most common acne type is known to be acne vulgaris (vulgaris means common), which is a common inflammatory skin disease with inflammatory or non-inflammatory lesions. Acne appears mostly on the face, but can also appear on the chest, back, and upper arms. Although it is usually not considered a dangerous medical condition, it can cause psychological distress and also even leads to skin scarring. Teenagers are the mostly affected group with around 85% of 16-18-year-olds believed to have some form of acne. The diet and nutrient intake will determine the overall health of an individual. The food that is rich in refined carbohydrates increases insulin, which results in hormonal problems, promoting acne formation.
The global Acne market is valued at million US$ in 2018 and will reach million US$ by the end of 2026, grown at a CAGR of x% during 2018-2026. More than 90% of the global population is known to be affected by acne at some point in their life. The global acne market represents a small fraction of total dermatology market and both over the counter drugs, and prescription drugs are used to treat acne. The acne market is primarily genericized and is moderately served by the currently marketed major prescribed drugs including Solodyn, Doryx, and Epiduo. The US market is the largest market for global acne products with about 60 million suffering from acne in the country. Thus, there is an increase in the adopting acne cure products that help in driving the overall market.
Dermatologists prefer to treat skin diseases through the use of topical applications or less invasive procedures compared to surgical methods. Usually, laser treatments offer a permanent solution for skin problems that reduce the growth of facial hair and pigmentation issues. To permanently minimize the occurrence of acne, clinicians suggest the use of combination therapy as a topical antibiotic with a retinoid. The currently available therapeutic options for acne treatment include several approaches such as antibacterial washes, retinoids, antibiotic pills, pulsed-light therapies, lasers, photodynamic therapy, and systemic isotretinoin. Differin gel, Onexton (clindamycin phosphate and benzoyl peroxide), Altreno are some of the FDA approved treatments for different types of acne. The acne product pipeline consists of a diverse set of molecules showing a majority of products in early-stage development, comprises a total of 64 programs at various stages of clinical development, 41 percent of products found to be in the preclinical and discovery stage.
The global acne market is set to experience favorable growth driven by factors such as an increase in the youth population, the rise in health care expenditure, and an upsurge in disposable income, and growth in a sedentary lifestyle. The technological advancements, increasing awareness programs about acne, and the rising preference for minimally invasive procedures are the major trends that are observed in this market. However, the growth of this market is constrained by challenges such as the entry of generic drugs, stringent regulations, and side effects of acne therapies.
The global acne market is segmented on the basis of therapeutic class, type, acne type, formulation, region, and end-user.
The key players of the Global Acne market include Allergan Plc., Johnson & Johnson, Nestle S.A. (Galderma S.A.), Mayne Pharma Group Limited, Mylan N.V., GlaxoSmithKline Plc (Stiefel Laboratories, Inc.), Pfizer Inc., Sun Pharmaceutical Industries Limited, Valeant Pharmaceuticals International, Inc. and Teva Pharmaceutical Industries Ltd.
The report covers in-depth analysis on Global Acne Market. The report assesses the market products pipeline by stage of development (early development, pre-clinical, clinical and in approval), by application (Non-inflammatory acne, Inflammatory acne and others). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.
The report includes in-depth company profiles of key players in Global Acne Market. The company profile includes key information on overview, financial highlights, product portfolio, business strategies, and key recent developments.
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.
Data Collation (Primary & Secondary)
In-house Estimation (Based on proprietary databases and Models)
Market-related information is assembled from both primary and secondary sources.
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.